Reprieve Cardiovascular, Inc.
medical devices
About
Decongestion treatment for patients presenting with Acute Decompensated Heart Failure (ADHF) is highly variable and unpredictable, resulting in suboptimal fluid removal, extended hospital stays (~4.9 days), and high-cost burden. Reprieve is bringing intelligence to decongestion management to safely accelerate fluid removal for every heart failure patient. Utilization of Reprieve as frontline therapy management will standardize the algorithm of care and bring predictability and efficiency to acute heart failure management.
Keywords
medical equipment manufacturing
medical devices
hospital & health care
Company Information
-
Employees 50
Location
459 Fortune Blvd, Milford, Massachusetts, United States, 01757
